Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α -glucosidase inhibitory activity, and molecular modeling studies

European Journal of Medicinal Chemistry
2016.0

Abstract

3-Thiazolylcoumarin derivatives 1-14 were synthesized via one-pot two step reactions, and screened for in vitro α-glucosidase inhibitory activity. All compounds showed inhibitory activity in the range of IC50 = 0.12 ± 0.01-16.20 ± 0.23 μM as compared to standard acarbose (IC50 = 38.25 ± 0.12 μM), and also found to be nontoxic. Molecular docking study was carried out in order to establish the structure-activity relationship (SAR) which demonstrated that electron rich centers at one and electron withdrawing centers at the other end of the molecules showed strong inhibitory activity. All the synthesized compounds were characterized by spectroscopic techniques such as EI-MS, HREI-MS, (1)H NMR and (13)C NMR. CHN analysis was also performed.

Knowledge Graph

Similar Paper

Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α -glucosidase inhibitory activity, and molecular modeling studies
European Journal of Medicinal Chemistry 2016.0
Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors
European Journal of Medicinal Chemistry 2017.0
Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton
European Journal of Medicinal Chemistry 2014.0
Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α‐glucosidase inhibitors
Bioorganic & Medicinal Chemistry Letters 2023.0
Hydrazinyl arylthiazole based pyridine scaffolds: Synthesis, structural characterization, in vitro α-glucosidase inhibitory activity, and in silico studies
European Journal of Medicinal Chemistry 2017.0
Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring
European Journal of Medicinal Chemistry 2013.0
Synthesis, α-glucosidase inhibition and molecular docking studies of novel thiazolidine-2,4-dione or rhodanine derivatives
MedChemComm 2017.0
Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes
Bioorganic & Medicinal Chemistry Letters 2021.0
2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors
Bioorganic & Medicinal Chemistry 2015.0
Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0